Zur Startseite
820К+ Patienten haben seit 2014 Hilfe erhalten
50 Länder
1,500 Kliniken
6K+ Bewertungen
3K+ qualifizierte Ärzte

Wie hoch sind die Kosten für diagnostische Verfahren und Behandlungsverfahren für das Lymphom in der Republik Korea?

Der Durchschnittspreis für Diagnose und Behandlung von Lymphom in Republik Korea beträgt $88,758, der Mindestpreis beträgt $1,060 und der Höchstpreis beträgt $275,000.
Republik KoreaTürkeiÖsterreich
Knochenmarktransplantationvon $55,000von $36,000von $140,000
Chemotherapie bei Brustkrebsvon $19,200von $1,200von $15,000
Chemotherapievon $2,800von $2,430von $2,500
CAR-T-Zelltherapievon $385,000von $150,000von $350,000
Autologe Knochenmarktransplantationvon $42,000von $31,500von $50,000
Daten von Bookimed geprüft (Stand: June 2026), basierend auf Patientenanfragen und offiziellen Angeboten von 115 Kliniken weltweit. Die Durchschnittskosten basieren auf echten Rechnungen (2025–2026) und werden monatlich aktualisiert. Die tatsächlichen Kosten können variieren.

Vorteile und Garantien von Bookimed

Direkte Preise

Bookimed erhebt keine zusätzlichen Gebühren für dem Lymphom-Behandlungspreise. Die Preise stammen aus den offiziellen Preislisten der Kliniken. Sie zahlen direkt in der Klinik für Ihre Behandlung bei Ihrer Ankunft im Land.

Nur geprüfte Kliniken und Ärzte

Bookimed setzt sich für Ihre Sicherheit ein. Wir arbeiten nur mit medizinischen Einrichtungen zusammen, die hohe internationale Standards bei der Behandlung von Lymphom einhalten und über die notwendigen Lizenzen verfügen, um internationale Patienten weltweit zu behandeln.

Kostenlose 24/7-Hilfe

Bookimed bietet kostenlose fachliche Unterstützung. Ein persönlicher medizinischer Koordinator unterstützt Sie vor, während und nach Ihrer Behandlung und hilft Ihnen bei allen Fragen. Sie sind auf Ihrer Lymphom-Behandlungsreise nie allein.

Warum wir?

Ihr persönlicher medizinischer Koordinator bei Bookimed

  • Unterstützt Sie in jeder Phase
  • Hilft bei der Auswahl der richtigen Klinik und des passenden Arztes
  • Sorgt für einen schnellen und bequemen Zugang zu Informationen

Die besten Kliniken für die Behandlung von dem Lymphom in der Republik Korea: 9 geprüfte Optionen und Preise

Das Bookimed-Klinikranking basiert auf datenwissenschaftlichen Algorithmen und bietet einen vertrauenswürdigen, transparenten und objektiven Vergleich. Dabei werden die Patientennachfrage, Bewertungsergebnisse (sowohl positiv als auch negativ), die Häufigkeit von Aktualisierungen der Behandlungsoptionen und Preise, die Reaktionsgeschwindigkeit und die Klinikzertifizierungen berücksichtigt.
Samsung Medical Center
Ewha Womans University Medical Center
Seoul National University Bundang Hospital (SNUBH)
Asan Medical Center
Gachon University Gil Medical Center

Empfehlungen für Sie

Diesen Inhalt teilen

Videogeschichten von Bookimeds Patienten

Dayana
Ich habe meinen Urlaub in Antalya mit einer medizinischen Untersuchung verbunden.
Verfahren: Frauenuntersuchung
Igor
Es war großartig! Transfer, Unterkunft, Behandlung – alles inklusive.
Verfahren: Zahnimplantat
Marina
Bookimed hat alles für mich erledigt. Ich musste mir um nichts Sorgen machen.
Verfahren: Frauenuntersuchung
Aktualisiert: 05/27/2022
Verfasst von
Mariia Mytrofankina
Mariia Mytrofankina
Copywriter (English und Deutsch)
Mehrsprachige medizinische Autorin mit über 5 Jahren Erfahrung und einem Master in Philologie und Übersetzung. Leitet Projekte zur globalen Gesundheitszertifizierung und LGBTQ+-Patientenversorgung.
Fahad Mawlood
Medizinischer Redakteur und Data Scientist
Allgemeinarzt. Gewinner von 4 wissenschaftlichen Preisen. Er diente in Westasien. Ehemaliger Teamleiter eines medizinischen Teams zur Betreuung arabischsprachiger Patienten. Jetzt Fahad ist verantwortlich für die Datenverarbeitung und die Genauigkeit der medizinischen Inhalte.
Fahad Mawlood Linkedin
Diese Seite enthält möglicherweise Informationen zu verschiedenen Erkrankungen, Behandlungen und Gesundheitsdiensten, die in verschiedenen Ländern verfügbar sind. Bitte beachten Sie, dass der Inhalt nur zu Informationszwecken bereitgestellt wird und nicht als medizinischer Rat oder Anleitung ausgelegt werden sollte. Bitte konsultieren Sie Ihren Arzt oder eine qualifizierte medizinische Fachkraft, bevor Sie eine medizinische Behandlung beginnen oder ändern.

Lymphom -Behandlung in Republik Korea

Diese FAQs stammen von echten Patienten, die über Bookimed medizinische Hilfe suchen. Die Antworten werden von erfahrenen medizinischen Koordinatoren und vertrauenswürdigen Klinikvertretern gegeben.

What are the reported remission success rates for lymphoma chemotherapy in Korea?

Lymphoma chemotherapy in Korea achieves remission rates between 85% and 90% for early-stage patients. Specialized clinical studies report an 87.6% complete remission rate for Hodgkin’s lymphoma. Aggressive B-cell subtypes like DLBCL reach approximately 84% remission. Major Seoul centers use advanced protocols for these results.

  • Hodgkin’s lymphoma: Remission rates reach 93% for early-stage cases using combined modality therapy.
  • DLBCL outcomes: Standard R-CHOP therapy achieves a 84.2% complete remission rate for patients.
  • T-cell lymphoma: NK/T-cell lymphoma protocols show remission success in 71% to 78% of cases.
  • Burkitt lymphoma: Specific R-hyper-CVAD regimens report a 75% complete remission rate in Korea.

Bookimed Expert Insight: Data shows a high concentration of expertise in Seoul. Facilities like Samsung Medical Center and Severance Hospital manage over 2 million patients annually. These high-volume centers report remission rates comparable to Western benchmarks. This is due to their rapid adoption of digital systems. Seoul National University Hospital has been fully digitalized since 2004. This digital accuracy helps specialists refine chemotherapy dosing for complex lymphoma subtypes.

Patient Consensus: Patients note that Korean protocols are intensive. They emphasize the importance of reaching clear PET scans early in the treatment process.

Is CAR T-cell therapy available for lymphoma patients in South Korea?

CAR T-cell therapy is available for lymphoma patients at several licensed medical centers in South Korea. Major institutions provide approved therapies like Kymriah and Yescarta for relapsed or refractory diffuse large B-cell lymphoma. Local centers often collaborate on domestic clinical trials to expand treatment accessibility.

  • Available therapies: Kymriah and Yescarta are approved for adult relapsed DLBCL cases.
  • Domestic options: South Korea approved Limcato in 2026 as its first homegrown therapy.
  • Licensed institutions: Approximately 14 hospitals like Samsung Medical Center are authorized for administration.
  • Diagnostic precision: Facilities use advanced PET/CT and cytogenetic bone marrow analysis for staging.
  • Treatment volume: Asan Medical Center treats over 180,000 patients annually with multidisciplinary oncology teams.

Bookimed Expert Insight: While South Korea ranks eighth globally in medical requests, its oncology infrastructure is exceptionally concentrated. Samsung Medical Center and Severance Hospital manage over 6,000,000 patients combined each year. This massive volume allows these centers to maintain dedicated CAR T-cell units. Such specialization often leads to smoother logistics for complex cellular processing than smaller regional hubs.

Patient Consensus: Patients note it is important to confirm eligibility through telemedicine before traveling for aggressive B-cell lymphoma treatments. Many highlight that coordinating professional translation and post-treatment monitoring is essential for a smooth experience at Seoul hospitals.

Which hospitals are considered leading centers for lymphoma treatment in Korea?

Leading centers for lymphoma treatment in South Korea include Samsung Medical Center, Asan Medical Center, and Seoul National University Hospital. These Seoul-based institutions provide advanced therapies like CAR-T cell therapy and hematopoietic stem cell transplants. Most facilities hold JCI or KOIHA accreditations for oncology excellence.

  • Asan Medical Center: Performs 65,000+ yearly operations with a high-volume bone marrow transplantation program.
  • Samsung Medical Center: Offers CAR-T cell therapy for refractory B-cell lymphoma with presidential-standard facilities.
  • Seoul National University Hospital: Performed 3,500+ hematopoietic stem cell transplants using advanced precision medicine protocols.
  • Severance Hospital: Features the country's first carbon-ion therapy facility for treating aggressive lymphoma cases.
  • SNU Bundang Hospital: Utilizes the BESTcare digital system to enhance diagnostic accuracy for refractory cancers.

Bookimed Expert Insight: Patient volume often indicates specialized expertise in Korea. Severance Hospital and Samsung Medical Center handle high annual patient counts, exceeding 2,000,000 people each. Our data shows these large academic centers often centralize clinical trials for immunotherapy. Choosing a high-volume center in Seoul typically ensures access to newer drug-based protocols not available regionally.

Patient Consensus: Patients emphasize seeking second opinions at multiple Seoul-based clinics to confirm aggressive lymphoma diagnoses. Many note that major teaching hospitals provide better English-speaking support for international oncology coordination.

Can Western lymphoma therapies be combined with Korean Traditional Medicine?

Integrating Western lymphoma therapies with Korean Traditional Medicine (KTM) is a standard practice in Seoul medical centers. Specialized hospitals combine chemotherapy or immunotherapy with acupuncture and herbal medicine. These protocols manage side effects like neuropathy and fatigue while supporting immune function during rigorous treatment cycles.

  • Symptom management: Acupuncture and moxibustion alleviate chemotherapy-induced nausea and peripheral neuropathy.
  • Immune support: Herbal formulas like Bojungikki-tang potentially enhance modern PD-1 blockade immunotherapy effects.
  • Integrated facilities: Specialized centers like Kyung Hee University Hospital offer supervised Western-KTM collaboration.
  • Safety monitoring: Medical teams track liver enzymes to prevent herb-drug interactions during chemotherapy.

Bookimed Expert Insight: Samsung Medical Center and Severance Hospital use digital systems like BESTcare to coordinate complex treatments for millions of patients. Our data shows that top-tier Seoul facilities often have KTM-integrated oncology referrals nearby. Patients should choose JCI-accredited hospitals that offer multidisciplinary tumor boards. These boards ensure traditional herbs do not interfere with advanced treatments like CAR T-cell therapy.

Patient Consensus: Patients note that getting oncologist approval for mild herbal teas often helps with post-chemo recovery and nausea. Many advise sticking strictly to hospital-approved herbs rather than over-the-counter options to avoid dangerous drug interactions.

What clinical documents should international patients bring for a lymphoma treatment plan?

Patients must bring complete medical records, including pathology slides, digital imaging, and detailed treatment logs. These documents ensure accurate diagnostic review and prevent treatment delays. South Korean cancer centers require recent scans and certified translations to confirm lymphoma staging and previous chemotherapy cycles.

  • Pathology materials: Bring physical glass slides and paraffin blocks for review.
  • Digital imaging: Provide original PET-CT and MRI scans in DICOM format.
  • Treatment records: Include specific chemotherapy drug names, dosages, and total cycles.
  • Blood results: Present recent panels including CBC, LDH, and beta-2 microglobulin.
  • Genetic data: Share molecular testing results like MYC or BCL2 markers.

Bookimed Expert Insight: Advanced centers like Samsung Medical Center and Asan Medical Center handle massive patient volumes, often exceeding 180,000 annually. This high traffic means diagnostic departments prioritize digital records over paper files for faster processing. Patients should bring three physical copies of all records, but keeping everything on a USB drive is the most efficient way to ensure Korean oncologists can integrate your history into their digital BESTcare systems immediately.

Patient Consensus: Patients emphasize that bringing physical pathology slides is essential to avoid repetitive biopsies that can cost $2,000. It is also important to have all files translated into Korean or English at least four weeks before traveling.

Where are Korea’s main medical hubs for lymphoma care located?

Seoul and Incheon serve as the primary hubs for lymphoma care in South Korea. These cities host Joint Commission International-accredited centers. They specialize in CAR T-cell therapy and bone marrow transplants. Patients access advanced diagnostics like PET-CT and cytogenetic analysis at these facilities.

  • Seoul oncology district: Houses Samsung Medical Center with dedicated CAR T-cell programs.
  • National Cancer Center: Located in Gyeonggi-do, this government facility leads in proton therapy.
  • Incheon medical hub: Gachon University Gil Medical Center provides multidisciplinary care near the airport.
  • Bone marrow focus: Seoul National University Hospital has performed over 3,500 bone marrow transplants.

Bookimed Expert Insight: Seoul centers demonstrate high-volume expertise rarely seen elsewhere. Asan Medical Center serves over 11,000 outpatients daily. This massive scale allows clinics like Seoul National University Bundang Hospital to implement digital systems that reduce medical errors. If seeking complex transplants, focusing on these high-capacity Seoul institutions ensures access to larger hematology teams.

Patient Consensus: Patients note that Seoul centers often provide faster treatment starts for aggressive lymphomas compared to US facilities. They frequently mention the benefit of having English-speaking coordinators at Samsung Medical Center to help navigate complex therapy schedules.

Kostenlose Beratung erhalten

Wählen Sie die beste Art und Weise, Sie zu kontaktieren